Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.58 USD | -0.56% | -1.10% | -18.26% |
May. 09 | Transcript : Eton Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Eton Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Eton Pharmaceuticals, Inc.
Upcoming events on Eton Pharmaceuticals, Inc.
Past events on Eton Pharmaceuticals, Inc.
2024-05-20 | Benchmark Healthcare House Virtual Conference |
2024-05-13 09:30 am | Citizens JMP Life Sciences Conference |
2024-05-09 04:30 pm | Q1 2024 Earnings Call |
2024-05-09 04:01 pm | Q1 2024 Earnings Release |
2024-03-14 04:30 pm | Q4 2023 Earnings Call |
2024-03-14 04:01 pm | Q4 2023 Earnings Release |
2023-11-09 04:30 pm | Q3 2023 Earnings Call |
2023-11-09 04:01 pm | Q3 2023 Earnings Release |
2023-10-03 03:30 pm | LD Micro Main Conference |
2023-09-13 09:00 am | H.C. Wainwright Global Investment Conference |
2023-08-10 04:30 pm | Q2 2023 Earnings Call |
2023-08-10 04:01 pm | Q2 2023 Earnings Release |
2023-06-13 11:00 am | Annual General Meeting |
2023-05-11 04:30 pm | Q1 2023 Earnings Call |
2023-05-11 04:01 pm | Q1 2023 Earnings Release |
2023-03-16 04:30 pm | Q4 2022 Earnings Call |
2023-03-16 04:01 pm | Q4 2022 Earnings Release |
2023-02-21 12:00 pm | Winter Wonderland Best Ideas Investor Conference |
2022-11-10 04:30 pm | Q3 2022 Earnings Call |
2022-11-10 04:05 pm | Q3 2022 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,96 1,17 -18.06% | 0,04 1,16 -96.64% | 21,8 23,3 -6.31% | 21,3 21,9 -2.84% | 31,6 32,0 -1.09% | 36,1 |
EBITDA Million USD | Released Forecast Spread | -18,2 -21,4 15.05% | -26,5 -25,4 -4.29% | -1,03 -0,09 -998.94% | 0,00 0,00 - | 0,00 0,00 - | -0,10 |
EBIT Million USD | Released Forecast Spread | -18,6 -20,6 9.82% | -27,1 -25,7 -5.52% | -1,50 -1,30 -15% | -8,26 -8,76 5.69% | -1,19 0,01 -23940% | -1,30 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,3 -20,4 10.02% | -28,0 -26,4 -5.97% | -1,96 -1,71 -14.19% | -9,02 -9,59 5.92% | -0,69 0,33 -306.29% | -1,70 |
Net income Million USD | Released Forecast Spread | -18,3 -20,4 10.02% | -28,0 -26,4 -5.97% | -1,96 -1,71 -14.19% | -9,02 -9,59 5.92% | -0,94 0,33 -380.24% | -1,70 |
EPS USD | Released Forecast Spread | -1,03 -1,15 10.17% | -1,33 -1,27 -5.14% | -0,08 -0,06 -33.33% | -0,36 -0,38 5.26% | -0,04 0,01 -500% | -0,06 |
Announcement Date | 05/03/20 | 16/03/21 | 16/03/22 | 16/03/23 | 14/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2,18 7,10 -69.35% | 7,36 7,77 -5.24% | 3,22 3,05 5.58% | 8,50 9,12 -6.81% | 5,30 4,56 16.42% | 12,0 6,51 84.31% | 7,03 6,26 12.29% | 7,31 7,66 -4.55% | 7,97 8,00 -0.42% | 8,80 | 9,40 | 10,0 | 9,30 | 10,5 |
EBITDA Million USD | Released Forecast Spread | -0,55 -1,40 60.86% | 0,00 | 0,88 | 0,97 | -0,06 | 1,09 | ||||||||
EBIT Million USD | Released Forecast Spread | -5,09 1,15 -543.5% | -1,34 1,01 -232.94% | -2,90 -3,62 19.98% | 1,06 0,56 88.3% | -2,53 -3,42 25.95% | 3,88 -2,10 284.99% | -0,55 -2,53 78.36% | -1,99 -0,80 -150.38% | -0,80 -1,60 50% | -1,70 | 0,60 | 0,70 | -0,30 | 0,80 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,33 0,85 -729.28% | -1,56 0,74 -311.11% | -3,05 -3,85 20.87% | 0,91 0,34 165.12% | -2,66 -3,64 26.96% | 4,56 -2,26 301.81% | -0,58 -2,68 78.41% | -2,01 -0,99 -103.75% | -0,81 -1,80 54.94% | -1,80 | 0,40 | 0,50 | -0,50 | 0,70 |
Net income Million USD | Released Forecast Spread | -5,33 0,85 -729.28% | -1,56 0,74 -311.11% | -3,05 -3,85 20.87% | 0,91 0,34 165.12% | -2,66 -3,64 26.96% | 4,56 -2,26 301.81% | -0,58 -2,68 78.41% | -2,26 -0,99 -128.8% | -0,81 -1,80 54.94% | -1,80 | 0,40 | 0,50 | -0,50 | 0,70 |
EPS USD | Released Forecast Spread | -0,21 -0,08 -162.5% | -0,06 0,03 -300% | -0,12 -0,15 20% | 0,04 0,01 300% | -0,10 -0,14 28.57% | 0,18 -0,09 300% | -0,02 -0,10 80% | -0,09 -0,04 -125% | -0,03 -0,05 33.33% | -0,07 | 0,02 | 0,02 | -0,02 | 0,03 |
Announcement Date | 12/05/22 | 11/08/22 | 10/11/22 | 16/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 14/03/24 | 09/05/24 | - | - | - | - | - |
Past sector events for Eton Pharmaceuticals, Inc.
2024-05-23 01:00 am | CALLIDITAS THERAPEUTICS AB: Q1 2024 Earnings Release |
2024-05-15 01:00 am | MERCK KGAA: Q1 2024 Earnings Release |
2024-05-12 | MEZZION PHARMA CO.,LTD.: Q1 2024 Earnings Release (Projected) |
2024-05-13 | OSCOTEC INC.: Q1 2024 Earnings Release |
2024-05-08 | SK BIOPHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
2024-05-08 04:05 pm | SUPERNUS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-06 | KISSEI PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
2024-05-06 | KYOWA KIRIN CO. LTD.: Q1 2024 Earnings Release |
2024-04-29 | YOUCARE PHARMACEUTICAL GROUP CO., LTD.: Q4 2023 Earnings Release |
2024-04-29 | HK INNO.N CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ETON Stock
- Calendar Eton Pharmaceuticals, Inc.